SuperSaturated Oxygen in STEMI to Reduce Infarct Size: A New FDA-Approved Therapy
We invite you to dine and learn about a newly approved therapy for anterior STEMI patients to further reduce infarct size. SSO2 Therapy delivers hyperbaric levels of oxygen to the LCMA following successful PCI. Join Gregg Stone, M.D., FSCAI and this esteemed panel to delve into the background, application, and data on SSO2 Therapy.